Although the primary objective of the study was to establish the maximum tolerated activity of Rhenium-186 HEDP in prostate cancer metastatic to bone, we also recorded PSA and alkaline phosphatase levels and performed follow up bone scans. The gene discussed is KLK3; the disease is prostate carcinoma.